Shilpa Gupta

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Metastatic Renal Cell Carcinoma

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Imran Safder, Henkel Valentine, Nicole Uzzo, John Sfakianos, Robert Uzzo, Shilpa Gupta, Jason R Brown, Daniel L Ranti, Elizabeth R Plimack, George Haber, Christopher Weight, Alexander Kutikov, Philip H Abbosh, Laura Bukavina
Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets. JCO precision oncology 8 (2024)
Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Ashish M Kamat, Andrea B Apolo, Marek Babjuk, Trinity J Bivalacqua, Peter C Black, Roger Buckley, Matthew T Campbell, Eva Compérat, Jason Alexander Efstathiou, Petros D Grivas, Shilpa Gupta, Neil J Kurtz, Donald Lamm, Seth P Lerner, Roger Li, David J McConkey, Joan Palou Redorta, Thomas Powles, Sarah P Psutka, Neal D Shore, Gary D Steinberg, Richard Sylvester, J Alfred Witjes, Matthew D Galsky
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Bradley Alexander McGregor, Wanling Xie, Elio Adib, Walter M Stadler, Yousef Zakharia, Aijai Alva, M Dror Michaelson, Shilpa Gupta, Elaine T Lam, Subrina Farah, Amin H Nassar, Xiao X Wei, Kerry L Kilbridge, Lauren C Harshman, Sabina Signoretti, Lynette M Sholl, David J Kwiatkowski, Rana R McKay, Toni K Choueiri
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma. JCO precision oncology 6 (2022)
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, Terence W Friedlander, Mehmet Asim Bilen, Shilpa Gupta, Sandy Srinivas, Jaime R Merchan, Rana R McKay, Daniel P Petrylak, Carolyn Sasse, Blanca Homet Moreno, Yao Yu, Anne-Sophie Carret, Jonathan E Rosenberg
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Archana M Agarwal, Catherine M Tangen, Maha H A Hussain, Shilpa Gupta, Melissa Plets, Primo N Lara, Andrea L Harzstark, Przemyslaw W Twardowski, Channing J Paller, Dylan M Zylla, Matthew R Zibelman, Ellis G Levine, Bruce J Roth, Amir Goldkorn, Daniel A Vaena, Manish Kohli, Tony Crispino, Nicholas J Vogelzang, Ian M Thompson, David I Quinn
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Ryon P Graf, Virginia Fisher, Richard S P Huang, Omar Hamdani, Ole V Gjoerup, Jennifer Stanke, James Creeden, Mia A Levy, Geoffrey R Oxnard, Shilpa Gupta
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma. JCO precision oncology 6 (2022)